• About
  • News
  • Projects
      Project 1 - Development of a Gene Therapy for Usher Syndrome Type 1B (USH1B)
        Project 2 - Evaluation of novel gene therapy approaches for USH2A
          Project 3 - Retina organoids as models for assessing pathomechanisms and effects of novel treatments inn retinal disorders
            Project 4 - Development of a one-time gene therapy for age-related macular degeneration
              Project 5 - Development of novel gene therapy strategies for treatment of autosomal dominant retinitis pigmentosa in a pig model
                Project 6 - Novel targets for gene therapy in diabetic retinopathy (DR)
                  Project 7 - RPE plasticity in the context of neurodegenerative disease: Understanding the limits, pushing the boundaries
                    Project 8 - Novel AI-based biomarkers for retinal gene therapy outcomes by integrating functional neuroimaging and retinal imaging
                      Project 9 - Integrating imaging, clinical and genetic data with machine learning to establish biomarkers for retinal diseases
                    • Project leaders
                    • Publications
                    1. DFG-Forschergruppe 5621
                    2. Publications
                    3. The versatile roles of retinal pigment epithelium in the pathophysiology of retinitis pigmentosa
                    press releases | 29/07/2025
                    Project 7

                    The versatile roles of retinal pigment epithelium in the pathophysiology of retinitis pigmentosa

                    Hanaa Ghanawi, Susanne F. Koch
                    PMID: 40669665 DOI: https://doi.org/10.1016/j.preteyeres.2025.101390

                    Abstract

                    Retinitis pigmentosa (RP) is a group of hereditary retinal diseases that lead to progressive vision loss, with most disease-causing genes expressed in rod photoreceptors and a smaller fraction in retinal pigment epithelium (RPE) cells. The RPE and photoreceptor cells share a symbiotic relationship characterized by close spatial and functional interactions that play a pivotal role in vision. Although the role of RPE is fundamental to the retina, its involvement in retinal pathogenesis, and, in particular, in RP remains underappreciated. In this review, we summarize morphological alterations in the RPE resulting from pathogenic mutations specific to RPE cells, as well as those occurring secondary to photoreceptor degeneration. We provide a comprehensive summary of how mutations in RPE-specific genes play a key role in the pathophysiology of RP. Finally, we discuss the latest therapeutic approaches, including AAV-mediated gene augmentation, RPE cell transplantation, and pharmacological interventions.

                    All DFG-Forschergruppe 5621 Press Releases

                    FOR 5621 Research unit

                    Coordination

                    Mathildenstr. 8
                    80336 Munich
                    +49 89 2180 77337
                    wnüp6412,vimsfulD_vfiuyziu/:mi
                    Login for editors
                    Imprint | Data-Safety

                    DFG-Forscher...

                    • News
                    • Projects
                      • Project 1 - Development of a Gene Therapy for Usher Syndrome Type 1B (USH1B)
                      • Project 2 - Evaluation of novel gene therapy approaches for USH2A
                      • Project 3 - Retina organoids as models for assessing pathomechanisms and effects of novel treatments inn retinal disorders
                      • Project 4 - Development of a one-time gene therapy for age-related macular degeneration
                      • Project 5 - Development of novel gene therapy strategies for treatment of autosomal dominant retinitis pigmentosa in a pig model
                      • Project 6 - Novel targets for gene therapy in diabetic retinopathy (DR)
                      • Project 7 - RPE plasticity in the context of neurodegenerative disease: Understanding the limits, pushing the boundaries
                      • Project 8 - Novel AI-based biomarkers for retinal gene therapy outcomes by integrating functional neuroimaging and retinal imaging
                      • Project 9 - Integrating imaging, clinical and genetic data with machine learning to establish biomarkers for retinal diseases
                    • Project leaders